Alpha Teknova (TKNO) Expected to Post Earnings on Wednesday

Alpha Teknova (NASDAQ:TKNO) is anticipated to issue its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Alpha Teknova to announce earnings of ($0.0833) per share and revenue of $10.9610 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 6:00 PM ET.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.01. The firm had revenue of $11.08 million during the quarter, compared to analysts’ expectations of $10.23 million. Alpha Teknova had a negative net margin of 41.07% and a negative return on equity of 24.32%.

Alpha Teknova Price Performance

NASDAQ TKNO traded down $0.10 during trading on Wednesday, reaching $4.99. 17,759 shares of the company traded hands, compared to its average volume of 187,460. The company has a debt-to-equity ratio of 0.20, a quick ratio of 3.60 and a current ratio of 4.59. The stock’s 50 day moving average price is $5.01 and its two-hundred day moving average price is $3.66. The company has a market cap of $267.46 million, a price-to-earnings ratio of -15.58 and a beta of 0.62. Alpha Teknova has a 1-year low of $1.91 and a 1-year high of $6.68.

Institutional Investors Weigh In On Alpha Teknova

Several large investors have recently made changes to their positions in TKNO. Susquehanna International Group LLP lifted its holdings in Alpha Teknova by 25.0% during the 3rd quarter. Susquehanna International Group LLP now owns 16,206 shares of the company’s stock valued at $100,000 after purchasing an additional 3,246 shares during the last quarter. Larson Financial Group LLC boosted its position in Alpha Teknova by 58.5% in the third quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after buying an additional 3,464 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Alpha Teknova by 123.1% during the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after buying an additional 4,504 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in Alpha Teknova by 7.9% during the third quarter. Bridgeway Capital Management LLC now owns 80,900 shares of the company’s stock worth $501,000 after buying an additional 5,900 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Alpha Teknova during the second quarter worth approximately $29,000. Institutional investors own 13.81% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Alpha Teknova presently has a consensus rating of “Reduce”.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.